DrugPatentWatch Database Preview
Atezolizumab - Biologic Drug Details
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
Summary for atezolizumab
| Tradenames: | 1 |
| Patents: | 30 |
| Applicants: | 1 |
| BLAs: | 2 |
| Suppliers: see list | 1 |
| Recent Clinical Trials: | See clinical trials for atezolizumab |
Recent Clinical Trials for atezolizumab
Identify potential brand extensions & biosimilar entrants
| Sponsor | Phase |
|---|---|
| BioNTech Small Molecules GmbH | Phase 1/Phase 2 |
| Rigshospitalet, Denmark | Phase 2 |
| Fundacion Oncosur | Phase 1 |
Pharmacology for atezolizumab
| Ingredient-type | Antibodies, Monoclonal, Humanized Antibodies, Monoclonal Antibodies |
| Mechanism of Action | Programmed Death Receptor-1-directed Antibody Interactions |
Patent Text Search: US Patents for atezolizumab
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Genentech Inc | TECENTRIQ | atezolizumab | INJECTABLE;INJECTION | 761034 | 001 | 2017-04-17 | Start Trial | The Rockefeller University (New York, NY) | 2032-08-13 | RX | search | |
| Genentech Inc | TECENTRIQ | atezolizumab | INJECTABLE;INJECTION | 761034 | 001 | 2017-04-17 | Start Trial | 2039-02-26 | RX | search | ||
| Genentech Inc | TECENTRIQ | atezolizumab | INJECTABLE;INJECTION | 761034 | 001 | 2017-04-17 | Start Trial | IBC Pharmaceuticals, Inc. (Morris Plains, NJ) | 2032-08-14 | RX | search | |
| Genentech Inc | TECENTRIQ | atezolizumab | INJECTABLE;INJECTION | 761034 | 001 | 2017-04-17 | Start Trial | Yeda Research and Development Co. Ltd. (Rehovot, IL) | 2034-03-12 | RX | search | |
| Genentech Inc | TECENTRIQ | atezolizumab | INJECTABLE;INJECTION | 761034 | 001 | 2017-04-17 | Start Trial | Yeda Research and Development Co. Ltd. (Rehovot, IL) | 2034-03-12 | RX | search | |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
International Patents for atezolizumab
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Japan | 5435432 | Start Trial |
| Japan | 4584363 | Start Trial |
| China | 101534865 | Start Trial |
| European Patent Office | 2651411 | Start Trial |
| Mexico | 342894 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
